Current insights and molecular docking studies of the drugs under clinical trial as RdRp inhibitors in COVID-19 treatment
… Effect of linagliptin plus insulin in comparison to insulin alone on metabolic control and prognosis in hospitalized patients with SARS-CoV-2 infection. Sci Rep 2022; 12(1): 536. http://dx.…..... Read More